Rare diseases
Investigational molecules
Locations
Back to France3 345 clinical trials in St Germain En Laye, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Evaluating denecimig as bleeding prophylaxis in adults with acquired haemophilia A
FranceStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
FranceStudy on the Safety and Effectiveness of GSK5733584 with Dostarlimab and Carboplatin for Patients with Advanced Gynecological Tumors
FrancePhase 3 Study of Pridopidine Hydrochloride for Safety and Efficacy in Adults with Huntington’s Disease
FranceA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
FranceA Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease
FranceA Study of ANX005 for Patients Recently Diagnosed with Guillain-Barré Syndrome to Evaluate How the Drug Works in the Body and Its Safety
FranceAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
FranceA study of MK-1084 and pembrolizumab for patients with resected KRAS G12C-mutant non-small cell lung cancer
FranceStudy of ATX-898 alone and in drug combination for patients with advanced solid tumors
FranceStudy of ZL-1310, BI 764532 and atezolizumab in patients with advanced small cell lung cancer and neuroendocrine tumors
FrancePhase 2 Study Evaluating Safety and Efficacy of Belzutifan in Adults with Solid Tumors
FranceThe busiest research cities in the country
What the registry says about research in the country
Investigating innovative combination therapies for follicular lymphoma, comparing mosunetuzumab plus lenalidomide against standard treatments to improve progression-free survival in previously untreated patients.
Research focuses on enhancing treatment outcomes for high-risk lymphoma patients.
Evaluating treatment strategies for elderly women with HER2-negative breast cancer, examining the effectiveness of combined chemotherapy and hormone therapy based on genomic profiling.
Studies aim to optimize treatment outcomes for senior patients while considering their specific needs.
Investigating treatment optimization for Secondary Progressive Multiple Sclerosis patients, focusing on the safety and efficacy of disease-modifying therapy withdrawal in stable patients over 50.
Research aims to enhance quality of life while maintaining disease stability.
Examining preventive strategies for pregnancy-associated hypertension and pre-eclampsia through controlled trials of acetylsalicylic acid treatment in pregnant women with chronic hypertension.
Focus on reducing maternal and fetal morbidity through preventive care.
Investigating the effects of preoperative cholecalciferol supplementation on post-thyroidectomy outcomes, specifically focusing on preventing hypocalcemia complications.
Research aims to improve patient recovery and reduce hospital stays after thyroid surgery.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
